Altre lingue Sumitomo Pharma Co., Ltd.

Azioni

4506

JP3495000006

Tempo differito Japan Exchange Altri mercati azionari 07:12:43 19/04/2024			Variaz. 5gg	Var. 1 gen.
392 ^JPY	-0,51%		-3,69%	-15,88%

17/04	SUMITOMO PHARMA CO., LTD. : Jefferies & Co. ribadisce il giudizio Neutral	ZM
02/04	Roivant Sciences afferma che lo studio sul potenziale trattamento dell'uveite ha raggiunto gli obiettivi; lancia un riacquisto di azioni; le azioni aumentano	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	02/04
Roivant's anti-inflammatory drug succeeds in mid-stage study	02/04
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03
Sumitomo Pharma Co., Ltd.(TSE:4506) dropped from S&P Japan 500	18/03
Sumitomo Pharma : Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Announces Availability of ORGOVYX in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer	13/03
US Inflation Report Lifts Asian Stock Markets	01/03
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
Japan's Nikkei slips after Fed chair signals delay in rate cut	01/02
Sumitomo Pharma Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	31/01
Sumitomo Pharma Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	31/01
Fed, China Property Outlooks Roil Asian Stock Markets	30/01
Poxel Announces its Financial Calendar for 2024	04/01
Japan's Nikkei rounds off 2023 with biggest yearly gain in a decade	29/12
Sumitomo Pharma : Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease in the United States	26/12
Poxel Provides Corporate Update	22/12
Interest Rates, China Housing Measures Lift Asian Stock Markets	15/12
Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting	12/12
China Real Estate, FX Roil Asian Stock Markets	29/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sumitomo Pharma Co., Ltd.

Azioni

4506

JP3495000006

Altre lingue

Filtri